ERIN DASHNAW: Open Payments
NPI 1235680513 · SOUTHBRIDGE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 78 payments from 13 companies in 2025. Trend: 2023 $589 · 2024 $1,356 · 2025 $1,677
Food & beverage: $1,465Education: $212
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $373 |
| ABBVIE INC. | 28 | $340 |
| Amgen Inc. | 13 | $323 |
| Regeneron Healthcare Solutions, Inc. | 6 | $212 |
| GENZYME CORPORATION | 2 | $81 |
| Galderma Laboratories, L.P. | 2 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Lilly USA, LLC | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| UCB, Inc. | 2 | $42 |
Products named: TREMFYA, Otezla, DUPIXENT, SKYRIZI, RINVOQ, NEMLUVIO, SPEVIGO, Bimzelx.
Industry payments across MA — which companies pay providers there.
